Justin Hanka Archives - Spark Newswire

2 minute read

Cannabis
Markets
News
Psychedelics

Microdosing For Depression: Psychedelics Biotech Signs $66.5M Non-Binding Deal To Out-License Novel Psilocin Prodrug Candidate

May 14, 8:00 AM

Psychedelics biotechÂ firm,Â Enveric Biosciences (NASDAQ:ENVB)Â has signed a non-binding term sheet to out-license a class of Novel Psilocin ProdrugsÂ (NPP)Â to Vancouver,…

ENVB

2 minute read

Cannabis
Markets
News
Psychedelics

MindBio Begins Recruitment Of Participants For LSD-Microdosing Clinical Trial In Cancer Patients Experiencing Emotional Distress

By Vuk Zdinjak

July 25, 9:12 AM

MindBio Therapeutics Corp.

CSE:MBIO

1 minute read

Cannabis
Markets
News

MindBio Phase 2 LSD-Microdosing Clinical Trial In Patients With Major Depressive Disorder Begins Pre-Screening Participants

By Vuk Zdinjak

July 19, 10:06 AM

MindBio Therapeutics Corp. (CSE:MBIO) (Frankfurt:WF6) have started pre-screening for participant entry into phase 2 LSD-microdosing clinical trials. The clinical trials are a for take home use of MindBio's LSD-microdosing treatment.

CSE:MBIO

Feed Tag: Justin Hanka

Microdosing For Depression: Psychedelics Biotech Signs $66.5M Non-Binding Deal To Out-License Novel Psilocin Prodrug Candidate

MindBio Begins Recruitment Of Participants For LSD-Microdosing Clinical Trial In Cancer Patients Experiencing Emotional Distress

MindBio Phase 2 LSD-Microdosing Clinical Trial In Patients With Major Depressive Disorder Begins Pre-Screening Participants